| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5896806 | Cytokine | 2016 | 8 Pages |
Abstract
Altogether, these results suggest that verproside could be a good therapeutic candidate for treatment of inflammatory airway diseases such as asthma and COPD by blocking the TNF-α/NF-κB signaling pathway.
Keywords
RIP1TRADDTAK1TNFRMUC5ACTRAF2IKKtransforming growth factor beta-activated kinase 1GAPDHNF-κBIκB kinaseNFκBchromatin immunoprecipitationChronic obstructive pulmonary diseaseCOPDtumor necrosis factor alphaTNF-αnuclear factor kappa BCHiPglyceraldehyde 3-phosphate dehydrogenasetumor necrosis factor receptor
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Su Ui Lee, Min Hee Sung, Hyung Won Ryu, Jinhyuk Lee, Hui-Seong Kim, Hyun Ju In, Kyung-Seop Ahn, Hyun-Jun Lee, Hyeong-Kyu Lee, Dae-Hee Shin, Yongnam Lee, Sung-Tae Hong, Sei-Ryang Oh,